(Q36449216)

14 August 2017

Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route (English)

1 reference

14 August 2017

1 reference

Robert S. Langer, Jr.

8

object named as

Robert Langer

1 reference

14 August 2017

Yiwei Qi

1

1 reference

14 August 2017

Ganlin Zhao

2

1 reference

14 August 2017

Dongfang Liu

3

1 reference

14 August 2017

Zachary Shriver

4

1 reference

14 August 2017

Mallik Sundaram

5

1 reference

14 August 2017

Shiladitya Sengupta

6

1 reference

14 August 2017

Ganesh Venkataraman

7

1 reference

14 August 2017

Ram Sasisekharan

9

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Proceedings of the National Academy of Sciences of the United States of America

14 August 2017

1 reference

14 August 2017

101

1 reference

14 August 2017

26

1 reference

14 August 2017

9867-9872

1 reference

Approaches in anticoagulation: rationales for target positioning.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Signalling to and from tight junctions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Sticky business: orchestrating cellular signals at adherens junctions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Rational design of low-molecular weight heparins with improved in vivo activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Current pharmacotherapeutic options for treating deep vein thrombosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Production and chemical processing of low molecular weight heparins.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Heparin in inflammation: potential therapeutic applications beyond anticoagulation.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Ex vivo evaluation of a Taylor-Couette flow, immobilized heparinase I device for clinical application

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

The role of hypercoagulability in venous and arterial thrombosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

A quest for the relief of atherosclerosis: potential role of intrapulmonary heparin--a hypothesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Thrombogenicity of factor IX complex: in vivo investigation

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Pharmacokinetics of heparin. II. Studies of time dependence in rats

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Pharmacokinetics of heparin. I. Studies of dose dependence in rats

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

28 June 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402891101

Acylated non-alpha-amino acids as novel agents for the oral delivery of heparin sodium, USP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402891101

Nasal administration of low molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402891101

Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402891101

Effect of inhaled heparin on lung function and coagulation in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402891101

Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino] caprylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402891101

Recent advances in pulmonary drug delivery using large, porous inhaled particles

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=470765

Assay of heparin in plasma using a chromogenic substrate for activated factor X

21 September 2018

1 reference

12 December 2020

Lung deposition and clearance of cadmium in rats exposed by inhalation or by intratracheal instillation

1 reference

12 December 2020

Large porous particles for pulmonary drug delivery

1 reference

12 December 2020

Inhaled heparin is effective in exacerbations of asthma

1 reference

12 December 2020

Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis

1 reference

12 December 2020

Oral delivery of new heparin derivatives in rats

1 reference

12 December 2020

Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0402891101

1 reference

14 August 2017

0 references

1 reference

14 August 2017

PubMed publication ID

15226520

1 reference